Our Expertise European Navigator
Solem's European Navigator leverages a series of proprietary tools tailored for life sciences companies, enabling them to map out a clear path towards realising the full value of their assets under development. Each tool aligns with the evolution of a company as they progress through clinical development planning, prelaunch and commercial phases.
Go further Global Solutions
Solem is an international life sciences consultancy committed to developing and executing tailored client solutions that navigate complex product development and commercialisation challenges, ensuring innovative treatments find their way to market and to patients in need.
A compelling alternative to outlicencing, we offer a de-risked model which gives our clients a detailed and comprehensive commercialisation solution across European and International markets. One which leverages a tailored launch plan, strategic brand plan and locally refined but fully integrated execution, all fulfilled by a bold team of in-market experts.
The Outlicencing Alternative
Solem’s powerful and driven team offers an unrivalled level of operational excellence that’s evolved across a broad portfolio of services and now covers a global marketplace. The capabilities first employed to dynamic effect in operational projects have formed the transformative backbone to our alternative commercialisation approach Globally.
Our People
Pete Zaudtke
Pete Zaudtke
PRINCIPAL
Pete is responsible for leading all operations relating to client projects. He developed many of the international capabilities that Solem possess whilst CFO and VP of Operations for a boutique oncology biotech, where he was responsible for the day to day operations of both the newly established US HQ and the EU subsidiary he opened.
Jürgen Reiher
Jürgen Reiher
PRINCIPAL
After authoring several of our proprietary Solem Navigator tools, Jürgen leads all our strategic planning and commercial implementation. Prior to joining Solem, throughout his career in pharma and as a consultant, he’s led the development of multiple strategic plans, complex market access dossiers, KOL engagements and management consulting projects.
Dr. Gabi Kothny-Wilkes
Dr. Gabi Kothny-Wilkes
PRINCIPAL
Dr Kothny has built an extensive track record of commercial success over many years at a global management level, as well as leading the direction and successful growth of multiple European oncology and hematology organizations and franchises. She now puts all her experience into helping pharma businesses achieve the results they need across global markets.
Jason Johnson
Jason Johnson
GLOBAL NEW BUSINESS DEVELOPMENT
Jason specialises in Business Development and Key Account Management within the European healthcare market and has a great track record of exceeding strategic objectives. He held a leading role across functions in the management and execution of multi-country solutions and has established enduring working partnerships by developing an understanding of corporate cultural nuances and procedural etiquette across Europe.
A NAVIGATOR CASE STUDY The value of a proven executable path.
When a biotech organisation adopted the common thought process of believing that prelaunch work would fall to the commercial partner, they suddenly found themselves concerned about being behind. We were able to launch our proven Navigator process to help bring our client back on schedule and avoided and delayed launch timescales.